Flagship Pioneering’s Post

We're thrilled to announce that we've appointed Percy Carter, MBA, Ph.D., to our Board of Directors! Dr. Carter has a strong track record of shaping and leading drug discovery and platform development. His leadership will help accelerate our work to bring value to patients via novel biology and differentiated drug candidates.      Welcome, Percy!

"We get to leverage incredible talent and expertise at Flagship Pioneering and across the ecosystem, which allows us to continuously improve as opposed to reinventing the wheel. With that operational efficiency, the amount of work we can accomplish for our size is astonishing and it means we can move fast to make medicines that benefit patients sooner." ➡ Read more about Brian Bouchard, Sr. Manager, Laboratory Operations at Pioneering Medicines, including his role in ensuring our growing lab footprint can support our ecosystem today and in the years to come. The latest installment in our 🌟employee spotlight series🌟, introducing you to the team members that are working tirelessly to improve human health and the sustainability of our planet. #WeAreFlagship 

We announced today that David M. Rubenstein, Co-Founder and Co-Chairman of The Carlyle Group, will join Moderna’s Board of Directors, effective August 5, 2024. Learn more: https://lnkd.in/e9hntUEu

YourBio Health Welcomes Mark Stevenson to Its Board of Directors! Mr. Stevenson, Senior Partner of Flagship Pioneering, with his extensive experience in commercializing life sciences and diagnostics innovations globally, is a valuable addition to the Board and will contribute significantly to the company's growth and success. “We enthusiastically welcome Mark Stevenson to YourBio Health’s Board of Directors,” said Paul Owen, President and CEO of YourBio Health. “Mark’s deep experience optimizing strategy, innovation, and operations in complex, global life sciences business environments will be invaluable to YourBio Health as we grow our business and pursue our mission to improve the blood collection experience for patients.” 🔍 Read the full article here: https://lnkd.in/exMdxQKB #BoardofDirectors #healthcareinnovation #medicaldevices

How can novel business models and international collaborations help emerging #biotech companies navigate the future of medical innovation? Empress co-founder and Chief Innovation Officer Sabrina Yang will be sharing her insights at #BIOAsiaTaiwan. See the agenda here: https://lnkd.in/gdi4Ph5g #Chemilogics #smallmolecule #drugdiscovery #AI #machinelearning #business #medtech #FlagshipFounded